Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Raymond Townsend currently holds 24,928 shares of Kindred Biosciences, Inc. (KIN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raymond Townsend has been a net seller of KIN stock. They have purchased $68.0K and sold $126.7K worth of shares.
Raymond Townsend's most recent insider trade was on Aug 27, 2021, when they sold 24,928 shares at $9.25 per share.
Raymond Townsend serves as Executive at Kindred Biosciences, Inc. (KIN). They have executed 21 insider transactions totaling $194.7K over their tenure at the company.
Raymond Townsend holds the position of Executive at Kindred Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Raymond Townsend has shown a selling trading pattern, with $68.0K in total purchases and $126.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Raymond Townsend was on Aug 27, 2021, when they sold $230.6K worth of KIN shares. This transaction involved 24,928 shares at $9.25 per share.
Raymond Townsend currently owns 24,928 shares of Kindred Biosciences, Inc. (KIN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Raymond Townsend's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Raymond Townsend has 21 Form 4 filings on record as an insider at Kindred Biosciences, Inc..
Set alerts for Raymond Townsend and 40,000+ other insiders.